Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles From Asymptomatic Tuberculosis Patients
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag086 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Luisa Maria Nieto Ramirez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomarkers, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIH, South African Medical Research Council.
Abstract (Originalsprache)
Background
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains the leading cause of death from a single infectious agent worldwide. Exposure to Mtb results in diverse outcomes: bacterial clearance, latent infection, asymptomatic, or symptomatic TB. Current diagnostic tools cannot reliably distinguish these outcomes. Our previous studies identified Mtb proteins in extracellular vesicles (EVs) from TB patients' serum, suggesting their potential as biomarkers. Here, we aimed to discover Mtb proteins and peptides in serum EVs across TB stages, focusing on asymptomatic individuals.
Methods
Serum was obtained from healthy, HIV-negative South African adult volunteers enrolled in a TB risk study. Based on patients' outcomes, samples were classified as prevalent, incident (controls that progressed to TB), activated TB, or community controls. EVs were isolated using ExoQuick™, followed by protein digestion and mass spectrometry (MS) analysis. Data-independent acquisition (DIA) with five different data analysis strategies, and two data-dependent (DDA) methods were used to identify Mtb proteins.
Results
Our DIA analysis using ion-mobility and spectral libraries enriched with Mtb-MS data revealed 19 Mtb proteins. Rv2997 was significantly higher at baseline in individuals who were initially TB-negative (incident) but later became bacteriologically positive, asymptomatic-TB (activated). HspX, GroEL2, and GroES, together with a MtrB peptide were significantly different between controls and asymptomatic-TB cases. DDA approaches did not resolve additional Mtb proteins.
Conclusions
Quantitative DIA analysis discovered Mtb proteins/peptides in serum-derived EVs that were differentially abundant in individuals with early, asymptomatic TB. These findings highlight their potential as biomarkers and provide insight into host–pathogen interactions during subclinical infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA.
- Bioanalysis and Omics Center, Analytical Resources Core, Colorado State University, Fort Collins, Colorado, USA.
- Division of Immunology, Department of Pathology, Faculty of Health Sciences, South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town, South Africa.
- Centre for the AIDS Programme of Research, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
- Aurum Institute, Johannesburg, South Africa.
- School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Luisa Maria Nieto Ramirez, Kimberly Shelton, Gustavo Diaz, Michèle Tameris, Kogieleum Naidoo, Gavin Churchyard, Thomas Scriba, Gerhard Walzl, Timothy R Sterling, Humphrey Mulenga, Mark Hatherill
Förderung
- NIAID NIH HHS
- NIH
- South African Medical Research Council
- NIAID
Zitieren
APA
Nieto Ramirez, L. M., Shelton, K., Belisle, J. T., Diaz, G., Tameris, M., Naidoo, K., Churchyard, G., Scriba, T., Walzl, G., Sterling, T. R., Hadley, K., Mulenga, H., Hatherill, M., & Dobos, K. M. (2026). Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles From Asymptomatic Tuberculosis Patients. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag086
Vancouver
Nieto Ramirez LM, Shelton K, Belisle JT, Diaz G, Tameris M, Naidoo K, et al. Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles From Asymptomatic Tuberculosis Patients. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag086
BibTeX
@article{NietoRamirez2026,
author = {Nieto Ramirez, Luisa Maria and Shelton, Kimberly and Belisle, John T and Diaz, Gustavo and Tameris, Michèle and Naidoo, Kogieleum and Churchyard, Gavin and Scriba, Thomas and Walzl, Gerhard and Sterling, Timothy R and Hadley, Kate and Mulenga, Humphrey and Hatherill, Mark and Dobos, Karen M},
title = {Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles From Asymptomatic Tuberculosis Patients},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag086}
}
EUVIMED